About the project
Title: BREEZE: A feasibility, randomised controlled trial of a complex breathlessness intervention in idiopathic pulmonary fibrosis (IPF)
Funder: NIHR Research for Patient Benefit
Time frame: 2018 - 2020
Contact for more details: Dr Michael Crooks (Clinical Sciences Centre) and Professor Miriam Johnson
The purpose of this project is to address the uncertainties relating to the design and conduct of a substantive phase 3 randomised controlled trial to evaluate a complex breathlessness intervention in patients with IPF and chronic breathlessness.
This study aims to find out whether a phase 3 trial is possible with regard to i) recruitment ii) delivery and use of the intervention iii) completion of study questionnaires and iv) the number of participants needed. Participants will be randomized to intervention “now” or intervention “8 weeks later” delivered by a specialist therapist. Assessment of breathlessness and quality of life and measurement of daily activity will be performed at the start of the study and repeated every four weeks for a total of 16 weeks.